Workflow
Zepp Health(ZEPP)
icon
Search documents
Zepp Health(ZEPP) - 2019 Q4 - Annual Report
2020-04-23 20:12
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR o SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITI ...
Zepp Health(ZEPP) - 2019 Q4 - Earnings Call Transcript
2020-03-13 19:22
Financial Data and Key Metrics Changes - In Q4 2019, revenue increased by 72.4% to RMB2.1 billion from RMB1.2 billion in Q4 2018 [20] - Net income attributed to Huami Corporation rose by 64.5% year-over-year [19] - Shipments reached 14.7 million units in Q4 2019, representing a 59.8% growth from 9.2 million units in the same quarter of 2018 [19][20] - Gross profit increased by 62.8% to RMB503 million, with a gross margin of 23.8%, down from 25.2% a year ago [21] - Total operating expenses rose by 60.6% to RMB285 million, reflecting increased investment in R&D and marketing [21][25] Business Line Data and Key Metrics Changes - The Amazfit brand expanded to seven smartwatch product lines, contributing to strong sales growth [8][9] - Approximately 51.6% of total products sold were shipped overseas, indicating a significant international presence [9] - In Q4 2019, Amazfit watch shipments increased by 440.1% in Western Europe [11] Market Data and Key Metrics Changes - Huami ranked number one in market share for smartwatches in India, Indonesia, and Spain [10] - The company experienced a 328.5% increase in shipments in markets outside the previously mentioned countries [11] - The European market saw rapid growth, with significant increases in shipments and market share [11] Company Strategy and Development Direction - The company aims to build a comprehensive health and fitness ecosystem through new product initiatives [12] - Continued collaboration with partners like Timex and Xiaomi is a key part of the strategy [13] - Focus on healthcare technology development, including partnerships for cloud-based healthcare services [14] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the impact of the COVID-19 outbreak on supply chains and operations, expecting some effects in Q1 2020 [15][27] - Despite challenges, management remains confident in achieving sustainable growth and profitability in 2020 [27] - The company plans to launch new products and expand into new markets, maintaining a focus on health and fitness [47][49] Other Important Information - The company donated medical supplies in response to the COVID-19 outbreak and is leveraging AI capabilities for health monitoring [16][17] - The next generation AI chip, Huangshan-2, is in development to enhance healthcare functionalities in future products [14] Q&A Session All Questions and Answers Question: Impact of COVID-19 on 2020 outlook - Management acknowledged supply chain impacts but remains confident in catching up losses in the latter part of the year [31][32] Question: Update on Timex collaboration - The first product, Timex Ironman R300, has been launched, and further products are expected in the first half of the year [33] Question: AI intelligence project updates - The company is engaged in partnerships with institutions like Stanford University for sleep research and algorithm improvements [35] Question: Shipment breakdown by region - Europe represents approximately one-third of overseas sales, with significant growth in various EU countries [37] Question: Gross margin factors - The blended margin decreased slightly due to strong sales of lower-margin Xiaomi products, but Amazfit margins improved [42] Question: Future product focus - The company will continue to focus on health and fitness products while exploring new market opportunities [49]
Zepp Health(ZEPP) - 2019 Q3 - Earnings Call Transcript
2019-11-12 16:29
Huami Corporation (HMI) Q3 2019 Earnings Conference Call November 12, 2019 7:30 AM ET Company Participants Grace Zhang - Director, Investor Relations Huang Wang - Chairman & Chief Executive Officer David Cui - Chief Financial Officer Mike Yeung - Chief Operating Officer Conference Call Participants Clive Cheung - Credit Suisse Arthur Lai - Citi Meng Cao - Industrial Securities Michelle Zhang - China Renaissance Xudong Chen - CICC Robert Cowell - 86Research Jason Sun - China Renaissance Operator Hello ladies ...
Zepp Health(ZEPP) - 2019 Q2 - Earnings Call Transcript
2019-08-19 23:07
Huami Corporation (HMI) Q2 2019 Results Earnings Conference Call August 19, 2019 9:00 AM ET Company Participants Grace Zhang - Director, Investor Relations Huang Wang - Chairman and CEO David Cui - Chief Financial Officer Mike Yeung - Chief Operating Officer Conference Call Participants Kyna Wong - Credit Suisse Xudong Chen - CICC Arthur Lai - Citi Joy Wei - 86 Research Operator Hello, ladies and gentlemen. Thank you for standing by for Huami Corporation’s Second Quarter 2019 Earnings Conference Call. At th ...
Zepp Health(ZEPP) - 2019 Q1 - Earnings Call Transcript
2019-06-03 15:51
Huami Corporation (HMI) Q1 2019 Results Earnings Conference Call June 3, 2019 8:00 AM ET Company Participants Grace Zhang - Director of IR Huang Wang - Founder, Chairman & CEO David Cui - CFO Mike Yeung - COO Conference Call Participants Kyna Wong - Credit Suisse Arthur Lai - Citi Robert Cowell - 86Research Presentation (Prepared remarks provided to Seeking Alpha by the company.) Operator Hello, ladies and gentlemen. Thank you for standing by for Huami Corporation First Quarter 2019 Earnings ...
Zepp Health(ZEPP) - 2018 Q4 - Annual Report
2019-04-12 12:06
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO S ...